Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.03
-0.37 (-6.85%)
At close: Jun 27, 2025, 4:00 PM
5.07
+0.04 (0.76%)
After-hours: Jun 27, 2025, 7:59 PM EDT

Recursion Pharmaceuticals Statistics

Total Valuation

RXRX has a market cap or net worth of $2.05 billion. The enterprise value is $1.64 billion.

Market Cap 2.05B
Enterprise Value 1.64B

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

RXRX has 406.92 million shares outstanding. The number of shares has increased by 44.28% in one year.

Current Share Class 399.66M
Shares Outstanding 406.92M
Shares Change (YoY) +44.28%
Shares Change (QoQ) +19.86%
Owned by Insiders (%) 4.40%
Owned by Institutions (%) 72.61%
Float 388.52M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 27.00
Forward PS 25.76
PB Ratio 2.22
P/TBV Ratio 4.65
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 27.42
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.10.

Current Ratio 4.11
Quick Ratio 3.85
Debt / Equity 0.10
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -278.66

Financial Efficiency

Return on equity (ROE) is -86.10% and return on invested capital (ROIC) is -48.52%.

Return on Equity (ROE) -86.10%
Return on Assets (ROA) -38.51%
Return on Invested Capital (ROIC) -48.52%
Return on Capital Employed (ROCE) -49.35%
Revenue Per Employee $74,738
Profits Per Employee -$718,469
Employee Count 800
Asset Turnover 0.06
Inventory Turnover n/a

Taxes

Income Tax -506,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -42.58% in the last 52 weeks. The beta is 0.83, so RXRX's price volatility has been lower than the market average.

Beta (5Y) 0.83
52-Week Price Change -42.58%
50-Day Moving Average 4.92
200-Day Moving Average 6.34
Relative Strength Index (RSI) 50.95
Average Volume (20 Days) 31,929,062

Short Selling Information

The latest short interest is 120.08 million, so 29.51% of the outstanding shares have been sold short.

Short Interest 120.08M
Short Previous Month 109.03M
Short % of Shares Out 29.51%
Short % of Float 30.91%
Short Ratio (days to cover) 4.45

Income Statement

In the last 12 months, RXRX had revenue of $59.79 million and -$574.78 million in losses. Loss per share was -$1.82.

Revenue 59.79M
Gross Profit -372.61M
Operating Income -574.03M
Pretax Income n/a
Net Income -574.78M
EBITDA -525.58M
EBIT -574.03M
Loss Per Share -$1.82
Full Income Statement

Balance Sheet

The company has $500.45 million in cash and $92.91 million in debt, giving a net cash position of $407.54 million or $1.00 per share.

Cash & Cash Equivalents 500.45M
Total Debt 92.91M
Net Cash 407.54M
Net Cash Per Share $1.00
Equity (Book Value) 933.95M
Book Value Per Share 2.30
Working Capital 442.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$388.83 million and capital expenditures -$8.87 million, giving a free cash flow of -$397.71 million.

Operating Cash Flow -388.83M
Capital Expenditures -8.87M
Free Cash Flow -397.71M
FCF Per Share -$0.98
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -960.08%
Pretax Margin -962.17%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RXRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -44.28%
Shareholder Yield -44.28%
Earnings Yield -28.08%
FCF Yield -19.43%
Dividend Details

Analyst Forecast

The average price target for RXRX is $7.00, which is 39.17% higher than the current price. The consensus rating is "Buy".

Price Target $7.00
Price Target Difference 39.17%
Analyst Consensus Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RXRX has an Altman Z-Score of 0.86 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.86
Piotroski F-Score 1